Procter & Gamble (PG) shares extended gains on Aug. 4 after the company announced a definitive agreement to acquire premium wellness and dietary supplement maker Thorne. The $3.8 billion all-cash transaction equips the NYSE-listed consumer staple giant with immediate scale in the rapidly expanding health and self-care market.
Despite recent gains, Procter & Gamble stock is down roughly 12% versus its year-to-date high in late February.
Significance of Thorne Acquisition for PG Shares
Taking over Thorne from private equity firm L Catterton represents a major strategic move for PG to accelerate growth across its Personal Health Care division.
Thorne has built a strong market presence in science-backed nutritional supplements, personalized health solutions, and wellness technology, generating over $500 million in revenue last year and targeting $650 million in 2026.
By adding Thorne’s premium brand portfolio, which has higher profit margins than traditional consumer packaged goods, Procter & Gamble positions itself to capture fast-growing demand in the global self-care industry.
All in all, the announcement is bullish for PG shares as it signals management is taking aggressive action to boost top-line growth and improve overall margin profile moving into fiscal 2027.
Should You Load Up on Procter & Gamble Stock?
Beyond revenue boost, acquiring Thorne expands P&G’s access to a highly coveted demographic.
Most of Thorne’s customer base comprises health-conscious consumers under the age of 40, a segment the giant has sought to engage more deeply across its core household brands.
Procter & Gamble can leverage its vast global distribution infrastructure, retail relationships, and supply chain efficiencies to scale Thorne’s reach globally.
Plus, integrating Thorne’s direct-to-consumer digital (DTC) model with its global marketing engine could unlock substantial commercial synergies.
Note that Procter & Gamble shares also currently pay a dividend yield of 2.94%, which makes them even more attractive to own in 2026.
How Wall Street Recommends Playing Procter & Gamble
It's also worth mentioning that Wall Street analysts remain constructive on PG shares for the remainder of 2026.
According to Barchart, the consensus rating on Procter & Gamble sits at “Moderate Buy” currently, with the mean price target of about $161, indicating potential upside of about 9% from here.
